38 results
Thumbnail

D1.242 - Early-Life Dietary Diversity and the Risk of Atopic Dermatitis: A Nationwide Population-Based Cohort Study

Thumbnail

D1.244 - Clinical heterogeneity of pediatric atopic dermatitis: latent class analysis

Thumbnail

D1.241 - Clinical and Immunological Phenotypes of Alopecia Areata in Children with Atopic Dermatitis

Thumbnail

D1.236 - The role of tissue resident memory cells in immunodermatological disorders: A Systematic Review

Thumbnail

D1.237 - Mental Health and Neurodevelopmental Comorbidities in Pediatric Atopic Dermatitis: A Retrospective Study and Literature-Based Perspective

Thumbnail

D1.238 - Natural history of early onset atopic dermatitis and risk factors for persistency using Korean National Health Service data

Thumbnail

D1.239 - Are Maternal Epidermal Lipid Profiles Associated with Atopic Dermatitis Development in Early Childhood?

Thumbnail

D1.240 - ATH-409, a selective and covalent ITK inhibitor, protects against atopic dermatitis in preclinical models

Thumbnail

D1.245 - The role of advanced glycation end products as facilitating factors in the pathogenesis of atopic dermatitis in pediatric patients

Thumbnail

D1.246 - Characterization of Unmet Need for Targeted Precision Medication in Atopic Dermatitis Due to Inadequate Response or Adverse Reactions to Dupilumab

Thumbnail

D1.247 - Changes in the sensitization profile in allergic contact dermatitis: comparison between two populations separated by 10 years in a secondary hospital in northern Portugal

Thumbnail

D1.248 - Intersection of Autoimmune Mechanisms: Coexistence of Celiac Disease and Chronic Urticaria

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials

Thumbnail

D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use

Thumbnail

D2.453 - Olfactory outcomes of dupilumab in patients with CRSwNP: A real-world prospective study

Thumbnail

D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD